Montréal Invivo
  • Business Directory
  • Newsletters
  • Events
  • News
  • FR
  • Montreal InVivo
    • Partners
    • Press releases
    • Job Opportunities
    • About
    • Governance
    • Team
  • The LSHT ecosystem
    • Portrait of the sector
      • Industry Snapshot
      • Portrait of the workforce and the next generation
      • Discover the jobs of the future
    • Niches of excellence
      • Artificial Intelligence
      • Digital health
      • Health technologies
      • Oncology
      • Personnalized Healthcare
      • Rare diseases
      • Biomanufacturing
      • RNA Therapies
      • Cellular Therapy
    • Entrepreneurial spotlight videos
  • Our actions
    • Studies and Analyses: Business Intelligence on the Sector
    • Mobilization
    • Project committees
    • Training and services
  • Our resources
  • Become partners
  • Home
  • Business Directory
  • Newsletters
  • Events
  • News
  • Montreal InVivo
    • Partners
    • Press releases
    • Job Opportunities
    • About
    • Governance
    • Team
  • The LSHT ecosystem
    • Portrait of the sector
      • Industry Snapshot
      • Portrait of the workforce and the next generation
      • Discover the jobs of the future
    • Niches of excellence
      • Artificial Intelligence
      • Digital health
      • Health technologies
      • Oncology
      • Personnalized Healthcare
      • Rare diseases
      • Biomanufacturing
      • RNA Therapies
      • Cellular Therapy
    • Entrepreneurial spotlight videos
  • Our actions
    • Studies and Analyses: Business Intelligence on the Sector
    • Mobilization
    • Project committees
    • Training and services
  • Our resources
  • Become partners
  • FRANçAIS
Back to documents
Other documents

On PMPRB reform, political leadership and evidence-based approach needed

17 Apr 2019

A letter sent to the Prime Minister of Canada, co-signed by Jason Field, President & CEO of Life Sciences Ontario, Frank Béraud, President & CEO of Montréal InVivo and Mel Wong, President & CEO of BioAlberta.

Response-to-PMO-Apr-17-19 - 0,61 MB
Documents

We suggest

29 Mar 2021

Étude sur le créneau des maladies rares – Sommaire exécutif 2021

11 Aug 2016
Studies and analysis

Indicateurs de compétitivité en Amérique du Nord

Le Québec parmi les 15 meilleures juridictions en Amérique du Nord. Découvrez la performance globale de notre province en termes de coût, d’économie, d’innovati...

11 Nov 2013
Other documents

Le Grand Montréal : les TI-Santé, un secteur émergent en pleine croissance

Découvrez les raisons d’investir dans le grand Montréal : Un large éventail de centres de recherche du fait de la présence de deux grands pôles : celui des TIC et ce...

Subscribe to our newsletters

Stay informed of the industry’s breaking news by subscribing to our different type of newsletters

I want to subscribe
Montréal Invivo
  • Press releases
  • Newsletters
  • Contact us
  • Privacy policy
514 987-9377
info@montreal-invivo.com
630 rue Sherbrooke Ouest, bureau 460, Montreal (Québec), H3A 1E4
All rights reserved 2025 Montréal Invivo Creation and Web Design PAR Design
×
facebook twitter X home map-marker map refresh clock chevron-left chevron-up chevron-right chevron-down angle-left angl-right angle-up angle-down angle-left angle-right angle-up angle-down fax phone book search envelope-o lock print play book calendar user share2 linkedin cloud-download youtube-play spinner calendar doc pdf svg